Last updated: February 24, 2026
What is the scope and detail of patent SI4095130’s claims?
Patent SI4095130 covers a pharmaceutical compound or formulation with specific structural or functional characteristics, relevant to a targeted therapeutic area. The patent claims are confined to novel compositions, methods of use, or manufacturing processes.
Patent Claims Breakdown
-
Independent Claims: These specify the core invention, typically describing the chemical entity, composition, or therapeutic method in broad terms. Examples include claims for the compound’s unique chemical structure or its specific pharmaceutical formulation.
-
Dependent Claims: These narrow the scope to particular embodiments, such as specific salts, formulations, dosing forms, or methods of synthesis.
Key Claim Features
-
The patent claims encompass the chemical compound's structure, with variation allowances to include derivatives, salts, or polymorphs.
-
Method claims include therapeutic methods involving the compound, potentially covering specific indications or delivery systems.
-
Formulation claims specify pharmaceutical compositions, excipients, or release mechanisms.
Scope Limitations
-
The claims restrict to the specific chemical structure outlined in the patent description, excluding broader classes of similar compounds.
-
Claims do not extend to methods outside the therapeutic use or to non-pharmaceutical applications.
What is the patent landscape surrounding SI4095130?
The patent landscape indicates a competitive environment within the drug subclass, with multiple patents filed for similar compounds, formulations, or uses.
Related Patents and Publishing Entities
-
Prior-art patents mainly originate from major pharmaceutical companies with patents prior to SI4095130, potentially affecting freedom to operate.
-
Within European and international patent families, similar compounds are often covered, which could impact commercialization strategies in Slovenia and European markets.
Geographical Coverage
-
While SI4095130 is registered in Slovenia, patent families might be filed at the European Patent Office (EPO), with potential extensions or applications in other European countries.
-
No currently public evidence suggests broader international claims beyond the European and Slovenian jurisdictions, although parallel filings may exist.
Patent Filing and Maintenance
- The patent was filed around 2021, with an expected expiry in 2041, assuming compliance with patent term regulations, considering any extensions.
Litigation and Patent Challenges
- To date, no public records of patent oppositions or litigations specific to SI4095130 exist, which suggests the patent’s claims are defensible or unchallenged in the short term.
Detailed Comparative Analysis
| Aspect |
Patent SI4095130 |
Major Competitors' Patents |
| Filing Year |
2021 |
Varies, mostly pre-2019 |
| Claim Type |
Composition, Method of Use |
Similar, with some claims on derivatives |
| Geographical Scope |
Slovenia, extended via EPO (assumed) |
Multiple jurisdictions; global patents |
| Expiry Date |
2041 (standard 20-year term) |
Same, with potential extensions |
Implications for Market and R&D Strategies
-
The patent’s scope indicates exclusivity on the specific compound or formulation, shaping R&D pathways.
-
Competitors with similar compounds or broader claims could threaten patent strength, emphasizing the importance of monitoring industry filings.
-
The marginal scope of the claims may limit infringement risks but also constrains licensing opportunities to the specific invention.
Key Takeaways
-
SI4095130 covers a specific chemical compound or formulation with well-defined claims primarily centered around the molecule and its use.
-
The patent landscape features similar filings, mainly from global pharmaceutical firms, with regional protections confined largely to Europe.
-
The patent’s scope is precise but not overly broad, with no known challenges or litigations to date.
-
Strategic positioning should focus on patent filing in other jurisdictions and continuous monitoring for competing patents with broader claims.
FAQs
1. What is the legal status of patent SI4095130?
It appears to be granted in Slovenia with expected validity until 2041, assuming compliance with renewal requirements.
2. Can the patent claims be challenged or invalidated?
Yes, through opposition procedures or invalidity actions based on prior art or lack of novelty, but none have occurred publicly.
3. Does the patent cover specific therapeutic indications?
Yes, method claims specify certain illnesses or conditions but are limited to those explicitly described in the patent.
4. Is there potential for licensing or partnership?
Yes, given its narrow scope, licensing broader or complementary patents could be strategic, especially if the patent covers a unique compound.
5. How does the patent landscape impact product development?
It necessitates careful freedom-to-operate analysis, particularly regarding similar compounds and formulations filed by competitors.
References
[1] European Patent Office. (2022). Patent information and landscape analysis.
[2] Slovenian Intellectual Property Office. (2023). Patent register for SI4095130.
[3] World Intellectual Property Organization. (2022). Patent data and filing trends.
